ERBB2-positive breast cancer cells are sensitive to inhibition of both FASN and malic enzyme 1 genes (Kourtidis A, Carkner RD, Eifert C, Brosnan MJ, Conklin DS; unpublished data). This evidence concerns the gene ERBB2 and breast cancer.